Synergistic Effect Between Apolipoprotein E and Angiotensinogen Gene Polymorphisms in the Risk for Early Myocardial Infarction (Molecular Diagnostics and Genetics) Synergistic Effect Between Apolipoprotein E and Angiotensinogen Gene Polymorphisms in the Risk for Early Myocardial Infarction (Molecular Diagnostics and Genetics)

Synergistic Effect Between Apolipoprotein E and Angiotensinogen Gene Polymorphisms in the Risk for Early Myocardial Infarction (Molecular Diagnostics and Genetics‪)‬

Clinical Chemistry 2000, Dec, 46, 12

    • €2.99
    • €2.99

Publisher Description

Apolipoprotein E (ApoE) [5] is a plasma protein involved in cholesterol transport. ApoE is encoded by a polymorphic gene on chromosome 19 (the APOE gene), and three alleles ([member of]2, [member of]3, and [member of]4) have been described. These alleles differ in the amino acids at residues 112 (Cys in [member of]3 and [member of]2, and Arg in [member of]4) and 158 (Arg in [member of]3, Cys in [member of]2, and Arg in [member of]4) (1,2). The APOE [member of]4 allele is a well-recognized risk factor for Alzheimer disease, and several case-control studies have described an increased risk for coronary artery disease (CAD) among [member of]4 carriers, with [member of]44 homozygotes showing an earlier onset of the disease (3-10). However, other authors have found a nonsignificantly increased or even a decreased frequency of the [member of]4 allele among CAD patients (11, 12). Compared with [member of]33 homozygotes, carriers of the [member of]2 and [member of]4 alleles showed decreased and increased LDL-cholesterol, respectively (13). The [member of]2 allele has also been associated with higher triglyceride concentrations (14). DNA polymorphisms in the angiotensinogen (AGT), angiotensin receptor type 1 (ATM), and angiotensin' converting enzyme (ACE) genes have been linked to the risk of developing cardiovascular diseases. Among these polymorphisms, the ACE insertion/ deletion (I/D) and the AGT-235M/T polymorphisms have been linked with differences in ACE and angiotensin II (Ang II) concentrations in plasma. Compared with individuals with an ACE-ID/II or AGT-MM/TM genotype, ACE-DD and AGT-TT genotypes have significantly higher concentrations of ACE and angiotensin, respectively (15,16). The ACE-DD and AGT-TT genotypes have been associated with an increased risk for CAD in some studies, but not others (17-19). Several metaanalyses have investigated the association of the ACE polymorphism with myocardial infarction (MI). Whereas some authors found evidence for an association between the DD genotype and MI, others failed to confirm this result and suggested a bias toward publishing positive associations (20-22).

GENRE
Science & Nature
RELEASED
2000
1 December
LANGUAGE
EN
English
LENGTH
18
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
PROVIDER INFO
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
226
KB
Platelet-Activating Factor Acetylhydrolase is Not Associated with Carotid Intima-Media Thickness in Hypercholesterolemic Sicilian Individuals (Lipids, Lipoproteins, And Cardiovascular Risk Factors) Platelet-Activating Factor Acetylhydrolase is Not Associated with Carotid Intima-Media Thickness in Hypercholesterolemic Sicilian Individuals (Lipids, Lipoproteins, And Cardiovascular Risk Factors)
2004
Apolipoprotein E Polymorphism in Cerebrovascular & Coronary Heart Diseases (Report) Apolipoprotein E Polymorphism in Cerebrovascular & Coronary Heart Diseases (Report)
2010
Association of Adiponectin Gene Variations with Risk of Incident Myocardial Infarction and Ischemic Stroke: A Nested Case-Control Study (Molecular Diagnostics and Genetics) Association of Adiponectin Gene Variations with Risk of Incident Myocardial Infarction and Ischemic Stroke: A Nested Case-Control Study (Molecular Diagnostics and Genetics)
2006
Association Between Genetic Variations of Apo AI-CIII-AIV Cluster Gene and Hypertriglyceridemic Subjects (Molecular Pathology and Genetics) Association Between Genetic Variations of Apo AI-CIII-AIV Cluster Gene and Hypertriglyceridemic Subjects (Molecular Pathology and Genetics)
1997
Taq1b Polymorphism of Cholesteryl Ester Transfer Protein (CETP) Gene in Primary Combined Hyperlipidaemia (Report) Taq1b Polymorphism of Cholesteryl Ester Transfer Protein (CETP) Gene in Primary Combined Hyperlipidaemia (Report)
2009
High-Density Lipoproteins High-Density Lipoproteins
2011
Impact of the Third Cholesterol Report from the Adult Treatment Panel of the National Cholesterol Education Program on the Clinical Laboratory (Special Report) Impact of the Third Cholesterol Report from the Adult Treatment Panel of the National Cholesterol Education Program on the Clinical Laboratory (Special Report)
2002
DNA Methylation Changes in Sera of Women in Early Pregnancy are Similar to Those in Advanced Breast Cancer Patients (Technical Briefs) DNA Methylation Changes in Sera of Women in Early Pregnancy are Similar to Those in Advanced Breast Cancer Patients (Technical Briefs)
2004
Colorectal Carcinoma Susceptibility and Metastases are Associated with Matrix Metalloproteinase-7 Promoter Polymorphisms (Technical Briefs) Colorectal Carcinoma Susceptibility and Metastases are Associated with Matrix Metalloproteinase-7 Promoter Polymorphisms (Technical Briefs)
2003
High-Sensitivity C-Reactive Protein As a Predictor of All-Cause Mortality: Implications for Research and Patient Care (Editorial) High-Sensitivity C-Reactive Protein As a Predictor of All-Cause Mortality: Implications for Research and Patient Care (Editorial)
2008
Biological Variation of Tumor Markers and Its Application in the Detection of Disease Progression in Patients with Non-Small Cell Lung Cancer (Technical Briefs) Biological Variation of Tumor Markers and Its Application in the Detection of Disease Progression in Patients with Non-Small Cell Lung Cancer (Technical Briefs)
2005
Hemoglobin Variants and Hemoglobin [a.Sub.1C] Analysis: Problem Solved?(Editorial) Hemoglobin Variants and Hemoglobin [a.Sub.1C] Analysis: Problem Solved?(Editorial)
2003